博士論文

Mechanisms for mTORC1 activation and synergistic induction of apoptosis by ruxolitinib and BH3 mimetics or autophagy inhibitors in JAK2-V617F-expressing leukemic cells including newly established PVTL-2

Icons representing 博士論文
The cover of this title could differ from library to library. Link to Help Page

Available in National Diet Library

Find on the publisher's website

国立国会図書館デジタルコレクション

Mechanisms for mTORC1 activation and synergistic induction of apoptosis by ruxolitinib and BH3 mimetics or autophagy inhibitors in JAK2-V617F-expressing leukemic cells including newly established PVTL-2

Persistent ID (NDL)
info:ndljp/pid/11299512
Material type
博士論文
Author
石田, 信也
Publisher
石田, 信也
Publication date
2018
Material Format
Digital
Capacity, size, etc.
-
Name of awarding university/degree
東京医科歯科大学,博士(医学)
View All

Notes on use at the National Diet Library

Search by Bookstore

Search by Bookstore

Read this material in an accessible format.

View materials in accessible formats for people with print disabilities (1Type)

Search by Bookstore

Read in Disability Resources

Bibliographic Record

You can check the details of this material, its authority (keywords that refer to materials on the same subject, author's name, etc.), etc.

Digital

Material Type
博士論文
Title
Mechanisms for mTORC1 activation and synergistic induction of apoptosis by ruxolitinib and BH3 mimetics or autophagy inhibitors in JAK2-V617F-expressing leukemic cells including newly established PVTL-2
Author/Editor
石田, 信也
Publication, Distribution, etc.
石田, 信也
Publication Date
2018
Publication Date (W3CDTF)
2018
Alternative Title
新規樹立PVTL-2を含むJAK2-V617F変異陽性白血病細胞株でのmTORC1活性化機構とBH3 mimeticsまたはオートファジー阻害薬とruxolitinibによる相乗的アポトーシス誘導機構
Degree grantor/type
東京医科歯科大学
Date Granted
2018-07-31
Date Granted (W3CDTF)
2018-07-31